Inosine triphosphate (ITP) and deoxyinosine triphosphate (dITP) exists in all cells. dITP is potentially mutagenic and the levels of these nucleotides are controlled by inosine triphosphate pyrophosphatase (ITPase, EC 3.6.1.19). Here we report the cloning, expression and characterization of a 21.5 kDa human ITPase (hITPase), an enzyme whose activity has been reported in many animal tissues and studied in populations but whose protein sequence has not been determined before. At the optimal pH of 10.0, recombinant hITPase hydrolyzed ITP, dITP and XTP to their respective monophosphates whilst activity with other nucleoside triphosphates was low. K m values for ITP, dITP and XTP were 0.51, 0.31 and 0.57 mM respectively and k cat values were 580 and 360 and 640 s -1 respectively. A divalent cation was absolutely required for activity. The gene encoding the hITPase cDNA sequence was localized by radiation hybrid mapping to chromosome 20p in the interval D20S113-D20S97, the same interval in which the ITPA inosine triphosphatase gene was previously localized. A BLAST search revealed the existence of many similar sequences in organisms ranging from bacteria to mammals. The function of this ubiquitous protein family is proposed to be the elimination of minor potentially mutagenic or clastogenic purine nucleoside triphosphates from the cell.
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ITP has been found in many animal tissues. It is generated by pyrophosphorylation or stepwise phosphorylation of IMP, an essential metabolite of purine biosynthesis and a precursor of both AMP and GMP (1) (2) (3) . The deoxyribonucleotide dITP may be generated from dATP by slow, non-enzymatic hydrolysis or by reduction of ITP (3) . Normally, the cellular ITP/dITP concentration is very low. The inability to demonstrate the synthesis of ITP/dITP in cellular preparations has been attributed to the presence in the cytoplasm of an inosine triphosphatase (ITPase), an enzyme that does not permit accumulation of these nucleotides (2) .
ITPase hydrolyzes ITP/dITP to IMP/dIMP and PPi. XTP is also a substrate but activity towards other purine nucleoside triphosphates is low, while no activity is found with IDP or IMP (2-6). Different studies have measured different K m values for ITP (2, (6) (7) (8) (9) (10) (11) (12) but in all cases an alkaline pH optimum and an absolute requirement for a divalent ion such as Mg 2+ or Mn 2+ has been found. The range of ITPase activity in erythrocytes from Caucasian populations has been measured as 120-320 µmol IMP produced / h / g hemoglobin (Hb) 1 . In one population study, evidence was presented that a deficiency of ITPase was responsible for the high level of ITP found in 7 of >6,000 samples from mainly unrelated individuals. The frequency of heterozygosity for ITPase deficiency in Caucasian populations is estimated to be approximately 5% (6, (13) (14) (15) . The gene coding for ITPase, ITPA, is located on the short arm of chromosome 20 (16) .
Although mammalian ITPase activities have been identified in human erythrocytes (9) , rabbit liver (10) and several rat tissues (17) , no gene has been cloned and characterized. Ham1p, was reported to be the product of a gene controlling sensitivity of yeast strains to 6-N-hydroxylaminopurine (HAP) (19) . This yeast protein is homologous to the Mj0226 protein, with about 30% sequence identity. Experiments with yeast HAM1 -mutants have
shown that adenine-requiring haploid strains are unable to grow on HAP as the sole adenine source (19, 20) , while E. coli transformed with the HAMI gene are resistant to HAP mutagenesis (21) . This phenomenon presumably occurs because the conversion of HAP to HAP triphosphate and subsequent incorporation into DNA is lethal (20) . Based on biochemical information and sequence similarity, these two proteins may be microbial ITP hydrolases that can convert mutagenic, non-canonical purine nucleoside triphosphates to monophosphates and thus protect DNA from the incorporation of modified purine bases.
Here we report the cloning, expression and characterization of a human ITPase, Reaction products were identified by high performance liquid chromatography.
Reaction mixtures described above but without inorganic pyrophosphatase were incubated at 37 ˚C for 10 min in a volume of 800 µl. The reaction was stopped by adding 200 µl 20% 7 TCA. Aliquots (10 µl) were injected on to a 4.6 × 250 mm Zorbax 300SB-C18 5 µm column (Hewlett Packard) at 30 ˚C Chromatography conditions were as described previously (23) .
Northern blot analysis -Multiple tissue Northern (MTN TM ) blots containing 2 µg of poly(A+) mRNA isolated from a variety of human tissues were purchased from Clontech.
Blots were probed with a full-length human ITPase cDNA that had been radioactively labeled with [α− 32 P]dCTP by random priming using a random primer labeling kit were the best substrates for the recombinant hITPase followed by GTP and dGTP (Fig. 2) . In the absence of inorganic pyrophosphatase, no Pi production was detected by the colorimetric assay. The hITPase showed very low activity towards other nucleoside triphosphates: UTP, (d)CTP, TTP and (d)ATP were hydrolyzed 10-100-fold less than dITP (Fig. 2 ). IDP and IMP were not hydrolyzed at all, showing that hITPase is a nucleoside triphosphate pyrophosphohydrolase. HPLC analysis confirmed the production of IMP and dIMP as primary products: no IDP or dIDP was observed (data not shown).
Similarly to the purified human erythrocyte ITPase, recombinant hITPase had an absolute requirement for Mg 2+ ions and a high Mg 2+ optimum (6, 12) . Activity increased sharply up to about 10 mM MgCl 2 and reached a plateau between about 30 and 100 mM (data not shown). The recombinant hITPase also had a markedly high pH optimum of approximately 10.0 in glycine buffer, similar to the value of 9.6 from previous reports (12) .
Activity in the absence of 1 mM DTT was about half that in its presence indicating a requirement (though not absolute) for reducing conditions (data not shown). When analyzed by gel filtration, the recombinant 23 kDa tagged hITPase behaved as a homogeneous 45 kDa dimer (Fig. 3 ).
With ITP, dITP and XTP as substrates, the recombinant hITPase followed MichaelisMenten kinetics but with clear evidence of inhibition at higher substrate concentrations, most easily seen in reciprocal Lineweaver-Burk plots of the data (Fig. 4) . Both substrate inhibition and inhibition by contaminating (d)NDPs have been documented before for this enzyme (6, 12) . For this reason, kinetic parameters were calculated by non-linear regression using data points only at concentrations that did not appear to result in inhibition according to visual analysis of the reciprocal plots ( Table 1) . Within the errors of the k cat / K m values calculated in this way, all three substrates appear to be used with similar efficiencies.
Tissue-specific expression of hITPase -To determine the size and distribution of hITPase mRNA transcripts, Northern blots containing 2 µg of polyA + RNA from different adult human tissues were probed with [ 32 P]dCTP-labeled hITPase cDNA. This revealed a transcript of about 1.4 kb in all 24 adult human tissues examined, with the most abundant expression in heart, liver, sex glands, thyroid and adrenal gland (Fig. 5) . These results were largely confirmed by cDNA microarray analysis, which showed heart, liver, thyroid and thymus tissues to have the highest normalized expression ratios of those examined compared to housekeeping genes (all >2.6, data not shown). PHDsec program (24) . Multiple sequence alignment of hITPase and related sequences revealed a new conserved protein family representing inosine triphosphatases from bacteria to mammals. In the alignment (Fig. 6) , the amino acid residues corresponding to positions comprising the nucleotide-binding site predicted by 3D-structural analysis of Mj0226 are shown (18) . Not all are conserved; however, in some cases the side chain may be of lesser importance than the backbone amide in binding the substrate (18) . (17) . These and other studies also suggested that the enzyme was located in the cytoplasm (6, 17) . We have confirmed this location by transfection of COS-7 cells with a construct in which hITPase was fused to the C-terminus of GFP. A diffuse, but clearly non-nuclear distribition of fluorescence was observed 3 .
Enzymological analysis of the recombinant human protein expressed from this cDNA clone showed a high specificity for the hydrolysis of ITP, dITP and XTP to their respective monophosphates. Characteristics of the recombinant enzyme were similar to those from earlier reports of ITPase isolated from human tissues, except the K m value for ITP, which at 0.51 mM was higher than those previously reported -0.13 mM (12) and 0.07 mM (6). Three different human populations have been reported with respect to their ITPase activity. The first has high activity, the second has a mean activity exactly 25% that of the first, while the third population has very low activity. A theoretical explanation of this study is that normal (active) and mutant (inactive) alleles exist in the population and that the ITPase is only active as a dimer with two normal subunits (14, 15) . In heterozygotes, only one of the four hypothetical dimers would be composed of two normal monomers, leading to 25% activity. Consistent with this hypothesis is our finding that recombinant hITPase behaves as a homogeneous dimer under physiological conditions. This agrees with results generated by structural analysis of Mj0226 (18 Hb) (p<0.0002) and it has been suggested that the resulting elevated ITP may inhibit the activity of glutamate decarboxylase, the enzyme responsible for generating the neurotransmitter γ-aminobutyric acid (27, 28) .
Possible explanations for this discrepancy are (i) different levels of inhibitory IDP in the
ITP and dITP can be incorporated into RNA and DNA respectively by polymerases (29) (30) (31) (32) . As an unusual nucleotide in RNA, inosine arising from incorporation from ITP could lead to the same effects on RNA sequence-specific interactions as the inosine arising from RNA editing by ADARs, adenosine deaminases that act on RNA (33, 34) . Therefore, effects on structure, translatability and degradation rate are all possible. Further, because 14 adenosine deamination can alter RNA structure, sequence-independent processes also could be affected.
The deoxyribonucleotide dITP behaves as a dGTP analogue and is incorporated opposite cytosine with about 50% efficiency. Both isolated nuclei and purified DNA polymerases rapidly incorporated dITP into DNA. In the presence of ATP, dITP is stabilized in extracts of nuclei (35) and E .coli (36) , allowing the possibility that a small amount of dIMP will also be incorporated into DNA in vivo. Although hypoxanthine DNA glycosylase can remove the base from DNA (37), evidence has been presented that this enzyme only efficiently removes a hypoxanthine base from an I-T base pair, while removal from an I-C base pair is 15-20 times slower (38) . Due to the relative stability of an I-C base pair, inosine can remain until the next round of DNA replication, increasing the risk of direct mutagenesis.
In vitro polymerase studies have shown that the presence of dITP in reaction mixtures may induce a high frequency of mutation (39, 40) . Other reports shows that ITP and IDP added to cell cultures can cause elevated rates of chromosomal structural aberrations (41, 42) .
In human erythrocytes ITP is continuously synthesized and broken down at a relatively high rate, forming a futile cycle that has been proposed to regulate the concentration of ATP. Additionally, ITP appears to be a substrate for the cartilage pyrophosphorylase associated with articular calcium crystal deposition (43) and a substrate for receptor/ G proteins to activate effector systems (44, 45) .
Other naturally occurring unusual purine nucleoside triphosphates could be considered as possible substrates of hITPase, such as the triphosphates of 6-N-hydroxyaminopurine (HAP) (46) and 2-amino-N 6 -hydroxyladenine (AHA) (47) . The HAM1 protein, the hITPase homologue in yeast, can control the sensitivity of yeast strains to HAP added in medium.
Overexpression of HAM1 can protect E. coli from both the toxic and mutagenic effects of HAP (21) . Therefore, Ham1p must be acting as a HAP triphosphate pyrophosphatase to 
Kinetic parameters of recombinant human ITPase
Kinetic constants were determined from data obtained using the colorimetric assay described in Experimental Procedures using data points only at concentrations that did not appear to result in substrate or product inhibition according to visual analysis of reciprocal plots. 
